|
Funding Opportunities
• Sources sought for contract opportunity to develop a Limb Loss and Preservation Registry! Please see the notice in FedBizOpps for more information Limb Loss and Preservation Registry
- NIH-NICHD-NCMRR-2018-16:
https://www.fbo.gov/index?s=opportunity&mode=form&id=707e6a8430bcfe46cae904dcd2164e72&tab=core&_cview=0
• Notice of Intent to Publish a Funding Opportunity Announcement to Support New Applications in Regenerative Medicine Innovation Projects (RMIP) (UG3/UH3 - Clinical Trial Required)
(NOT-HL-18-573;
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-18-573.html)
Multiple Institutes
• Notice of Intent to Publish a Funding Opportunity Announcement to Support New Applications in Regenerative Medicine Innovation Projects (RMIP) (U01 - Clinical Trial Not Allowed)
(NOT-HL-18-574;
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-18-574.html)
Multiple Institutes
• Notice of Intent to Publish a Funding Opportunity Announcement to Support New Applications in Regenerative Medicine Innovation Projects (RMIP) (UT1/UT2 - Clinical Trial Required)
(NOT-HL-18-575;
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-18-575.html)
Multiple Institutes
• Notice of Intent to Publish a Funding Opportunity Announcement to Support New Applications in Regenerative Medicine Innovation Projects (RMIP) (UT1/UT2 - Clinical Trial Not Allowed)
(NOT-HL-18-576;
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-18-576.html)
Multiple Institutes
• Notice of Intent to Publish a Funding Opportunity Announcement to Support New Applications in Regenerative Medicine Innovation Projects (RMIP) (U43/U44 - Clinical Trial Required)
(NOT-HL-18-577;
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-18-577.html)
Multiple Institutes
• Notice of Intent to Publish a Funding Opportunity Announcement to Support New Applications in Regenerative Medicine Innovation Projects (RMIP) (U43/U44 - Clinical Trial Not Allowed)
(NOT-HL-18-578;
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-18-578.html)
Multiple Institutes
• PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
(PA-18-573;
https://grants.nih.gov/grants/guide/pa-files/PA-18-573.html)
Multiple Institutes
Application Receipt/Submission Date(s): Standard dates apply
• PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
(PA-18-574;
https://grants.nih.gov/grants/guide/pa-files/PA-18-574.html)
Multiple Institutes
Standard Dates apply
• PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
(PA-18-575;
https://grants.nih.gov/grants/guide/pa-files/PA-18-575.html)
Multiple Institutes
Standard Dates Apply
• PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
(PA-18-576;
https://grants.nih.gov/grants/guide/pa-files/PA-18-576.html)
Multiple Institutes
Standard Dates Apply
• Pediatric Device Consortia Grants Program (P50)
(RFA-FD-18-004;
https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-18-004.html)
Food and Drug Administration
Application Receipt Date(s): March 1, 2018, by 11:59 PM Eastern Time. December 1, 2018, by 11:59 PM Eastern Time. December 1, 2019, by 11:59 PM Eastern Time. December 1, 2020, by 11:59 PM Eastern Time. December 1, 2021, by 11:59 PM Eastern Time.
• NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U01 - Clinical Trial Optional)
(PAR-18-561;
https://grants.nih.gov/grants/guide/pa-files/PAR-18-561.html)
National Institute of Neurological Disorders and Stroke
Application Receipt/Submission Date(s): Standard dates apply
• NIH StrokeNet Small Business Innovation Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U44 - Clinical Trials Optional)
(PAR-18-563;
https://grants.nih.gov/grants/guide/pa-files/PAR-18-563.html)
National Institute of Neurological Disorders and Stroke
Application Receipt/Submission Date(s): Standard dates.
• Lab to Marketplace: Tools for Brain and Behavioral Research (R43/R44 - Clinical Trial Optional
(PAR-18-565;
https://grants.nih.gov/grants/guide/pa-files/PAR-18-565.html)
National Institute of Mental Health
Application Receipt/Submission Date(s): Standard dates apply.
• BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (U44 Clinical Trial Required)
(RFA-NS-18-022;
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-022.html)
Multiple Institutes. Application Receipt Date(s): February 23, 2018, June 21, 2018, October 22, 2018, February 21, 2019, June 21, 2019, October 21, 2019, February 21, 2020, June 22, 2020, October 21, 2020.
• BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UH3 - Clinical Trial Required)
(RFA-NS-18-023;
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-023.html)
Multiple Institutes
Application Receipt Date(s): February 23, 2018, June 21, 2018, October 22, 2018, February 21, 2019, June 21, 2019, October 21, 2019, February 21, 2020, June 22, 2020, October 21, 2020.
• Self-Management for Health in Chronic Conditions (R01 Clinical Trial Optional)
(PA-18-376;
https://grants.nih.gov/grants/guide/pa-files/PA-18-376.html)
National Institute of Nursing Research
National Institute on Aging
Application Receipt/Submission Date(s): Standard dates apply.
• Community Partnerships to Advance Research (CPAR) (R01 Clinical Trial Optional)
(PA-18-377;
https://grants.nih.gov/grants/guide/pa-files/PA-18-377.html)
National Institute of Nursing Research
Application Receipt/Submission Date(s): Standard dates apply.
• Community Partnerships to Advance Research (CPAR) (R21 Clinical Trial Optional)
(PA-18-381;
https://grants.nih.gov/grants/guide/pa-files/PA-18-381.html)
National Institute of Nursing Research
Application Receipt/Submission Date(s): Standard dates apply.
• Self-Management for Health in Chronic Conditions (R21 Clinical Trial Optional)
(PA-18-384;
https://grants.nih.gov/grants/guide/pa-files/PA-18-384.html)
National Institute of Nursing Research
National Institute on Aging
Application Receipt/Submission Date(s): Standard dates apply
• Self-Management for Health in Chronic Conditions (R15 Clinical Trial Not Allowed)
(PA-18-474;
https://grants.nih.gov/grants/guide/pa-files/PA-18-474.html)
National Institute of Nursing Research
National Institute on Aging
Application Receipt/Submission Date(s): Standard dates apply.
• Community Partnerships to Advance Research (CPAR) (R15 Clinical Trial Not Allowed)
(PA-18-475;
https://grants.nih.gov/grants/guide/pa-files/PA-18-475.html)
National Institute of Nursing Research
Application Receipt/Submission Date(s): Standard dates apply
• Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp - Clinical Trial Not Allowed)
(PA-18-517l;
https://grants.nih.gov/grants/guide/pa-files/PA-18-517.html)
Multiple Institutes
Application Receipt/Submission Date(s): March 5, 2018.
• Research on the Mechanisms and/or Behavioral Outcomes of Multisensory Processing (R01 - Clinical Trial Optional)
(PA-18-545;
https://grants.nih.gov/grants/guide/pa-files/PA-18-545.html)
Multiple Institutes
Application Receipt/Submission Date(s): Standard dates apply.
• NeuroNEXT Clinical Trials (U01 - Clinical Trial Optional)
(PAR-18-528;
https://grants.nih.gov/grants/guide/pa-files/PAR-18-528.html)
National Institute of Neurological Disorders and Stroke
Application Receipt/Submission Date(s): Standard dates apply.
• Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01)
(PAR-18-534;
https://grants.nih.gov/grants/guide/pa-files/PAR-18-534.html)
National Institute of Neurological Disorders and Stroke
Application Receipt/Submission Date(s): February 15, 2018; August 17, 2018.
• Translational Neural Devices (UG3/UH3/U44) (Next Due Date: February 21, 2018): The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications to pursue translational activities and small clinical studies to advance the development
of therapeutic, and diagnostic devices for disorders that affect the nervous or neuromuscular systems. The translational device activities, including translational bench and animal studies, are expected to lead to submission of an Investigational Device Exemption
(IDE) to the U.S. Food and Drug Administration (FDA) or Institutional Review Board (IRB) application for a Non-Significant Risk (NSR) study. This cooperative agreement will also support the subsequent small clinical trial to collect safety and effectiveness
data required to support a marketing application or to inform final device design. For more information visit:
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-011.html For the Small Business Innovation Research version visit:
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-012.html
• The Center for Neuroscience and Regenerative Medicine (CNRM), a collaborative intramural federal program between the USU (DoD) and NIH to study TBI and PTS, has released a funding opportunity (FOA # VP-18-005) in which they invite extramural researchers to
collaborate with Intramural researchers to address the following priorities:
Prioritized order of programmatic relevance will be as follows:
1) Interventional trials in military TBI patients or with direct relevance to military TBI patients.
2) Interventional trials in animal models with direct relevance to military TBI.
3) Planning and technical development grants in preparation for interventional trials in military TBI patients or with direct relevance.
4) Planning and technical development grants in preparation for interventional trials in animal models with direct relevance to military TBI.
5) Other relevant TBI projects.
General information
a.) Principal Investigator (PI) Eligibility Requirements:
• PI must have a faculty level appointment, or equivalent, and independent resources to lead the proposed research program.
• PI must hold a primary appointment at USU, WRNMMC, NIH, or Fort Belvoir Community Hospital.
• PI’s that do not have a primary appointment at one of the above listed institutions must include a Co-PI with a primary appointment at USU or intramural NIH.
b.) Overall Schedule:
Announcement release date: December 18, 2017 Pre-proposal LOI due date: January 30, 2018 Notification of invitation to submit full proposal: February 21, 2018 Invited proposal due date: April 23, 2018
For more information go to:
https://www.dropbox.com/s/ro25lkte6by7v1e/CNRM_FOA_%20FY18%2012.18.17_final.pdf?dl=0
If you have questions please direct them to: Program Officer, Julie Wilberding, Ph.D., MA, Direct: 301-319-0608, Email:
[log in to unmask]
|
